RETATRUTIDE, 20 mg

Retatrutide is a long‑acting triple‑agonist research peptide targeting the GLP‑1, GIP, and glucagon receptors. Its multi‑pathway design has made it a focal point in metabolic research exploring mechanisms related to energy balance, glucose regulation, and body‑weight dynamics.

⚠️ For Research Use Only
This product is not for human or veterinary use. It is intended strictly for laboratory research. Any mention of effects is based on scientific literature and does not imply approval by Health Canada or any regulatory agency.